MARKET

AKRO

Akero Therapeutics
AKRO
NASDAQ
Delisted
P/E
P/S
P/B
MARKET CAP
-14.5563
-
4.574
4,499,030,919.25
Cantor Fitzgerald Suspends Overweight Rating on Akero Therapeutics
Benzinga · 12/10/2025 13:56
Akero Therapeutics Announces Merger and Delisting Plans
TipRanks · 12/09/2025 14:27
*Novo Nordisk Has Acquired Akero For $54 a Share Plus Additional $6 a Share Based on Milestones
Dow Jones · 12/09/2025 13:54
Novo Nordisk Completes Acquisition of Akero Therapeutics
Reuters · 12/09/2025 13:51
NOVO NORDISK - COMMON STOCK OF AKERO WILL NO LONGER BE LISTED OR TRADED ON NASDAQ GLOBAL SELECT MARKET
Reuters · 12/09/2025 13:51
NASDAQ TRADE HALT <AKRO.O> TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Reuters · 12/09/2025 00:50
Weekly Report: what happened at AKRO last week (1201-1205)?
Weekly Report · 12/08/2025 09:05
GERMANY'S CARTEL OFFICE SAYS IT APPROVED ACQUISITION OF AKERO THERAPEUTICS BY NOVO NORDISK
Reuters · 12/04/2025 09:37
More

Webull offers Akero Therapeutics stock information, including NASDAQ: AKRO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AKRO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AKRO stock methods without spending real money on the virtual paper trading platform.